Investing News
Market News
Technology
The Market Buzz
Bayer Announces Acquisition of Asklepios BioPharmaceutical to Further Cell and Gene Therapy
Bayer AG reported the acquisition of Asklepios BioPharmaceutical, Inc. to broaden innovation base in pre-clinical and clinical stage candidates for the treatment of neuromuscular, central nervous system, cardiovascular and...